Biogen (Germany) Analysis

IDP Stock   141.10  0.95  0.67%   
Biogen Inc is overvalued with Real Value of 122.76 and Hype Value of 141.1. The main objective of Biogen stock analysis is to determine its intrinsic value, which is an estimate of what Biogen Inc is worth, separate from its market price. There are two main types of Biogen's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Biogen's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Biogen's stock to identify patterns and trends that may indicate its future price movements.
The Biogen stock is traded in Germany on XETRA Stock Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Biogen is usually not traded on GermanUnityDay, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, International Workers ' Day. Biogen Stock trading window is adjusted to Europe/Berlin timezone.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Biogen Stock Analysis Notes

About 90.0% of the company shares are owned by institutional investors. The book value of Biogen was currently reported as 92.98. The company recorded earning per share (EPS) of 19.5. Biogen Inc had not issued any dividends in recent years. The entity had 3:1 split on the 18th of January 2001. To learn more about Biogen Inc call Christopher Viehbacher at 617 679 2000 or check out https://www.biogen.com.

Biogen Inc Investment Alerts

Biogen Inc generated a negative expected return over the last 90 days
Over 90.0% of the company shares are owned by institutional investors

Biogen Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 36.46 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biogen's market, we take the total number of its shares issued and multiply it by Biogen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Biogen Profitablity

Biogen's profitability indicators refer to fundamental financial ratios that showcase Biogen's ability to generate income relative to its revenue or operating costs. If, let's say, Biogen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Biogen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Biogen's profitability requires more research than a typical breakdown of Biogen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.3 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.3 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.3.

Technical Drivers

As of the 21st of December, Biogen shows the Risk Adjusted Performance of (0.16), standard deviation of 1.67, and Mean Deviation of 1.17. Biogen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Biogen Inc Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Biogen middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Biogen Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Biogen Outstanding Bonds

Biogen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biogen Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biogen bonds can be classified according to their maturity, which is the date when Biogen Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Biogen Predictive Daily Indicators

Biogen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biogen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Biogen Forecast Models

Biogen's time-series forecasting models are one of many Biogen's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biogen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Biogen to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module

Additional Tools for Biogen Stock Analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.